Two Sigma Investments’s Kiora Pharmaceuticals KPRX Stock Holding History

Two Sigma Investments’s Portfolio KPRX Stock Details KPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234K	Buy	+88,792	New	+$223K	﹤0.01%	4683
2025 Q4	–	Sell	-11,984	Closed	-$33.3K	–	4255
2025 Q3	$33.3K	Buy	+11,984	New	+$32.9K	﹤0.01%	3564
2024 Q2	–	Sell	-1,150	Closed	-$7.31K	–	3189
2024 Q1	$7.31K	Buy	+1,150	New	+$6.43K	﹤0.01%	2965
2021 Q3	–	Sell	-75	Closed	-$99K	–	4488
2021 Q2	$99K	Sell	75 -72	-49%	-$112K	﹤0.01%	3899
2021 Q1	$263K	Buy	+147	New	+$320K	﹤0.01%	3433

Other funds holding KPRX

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Two Sigma Investments's KPRX Position: Q2 2026 in Review

Two Sigma Investments opened a new position in Kiora Pharmaceuticals (KPRX) in Q2 2026: 88,792 shares worth $234K. The stake represents ﹤0.01% of the portfolio and ranks #4683 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in KPRX as recently as Q3 2025.

Two Sigma Investments first reported a position in KPRX in Q1 2021 and has held it in 5 quarters since. The position peaked at $263K in Q1 2021. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

Two Sigma Investments held 88,792 shares of Kiora Pharmaceuticals worth $234K as of Q2 2026.
Kiora Pharmaceuticals was a new Two Sigma Investments position in Q2 2026.
Kiora Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #4683 holding.
Two Sigma Investments first reported a position in Kiora Pharmaceuticals in Q1 2021 and has held it in 5 quarters since.
Two Sigma Investments's Kiora Pharmaceuticals position peaked at $263K in Q1 2021.
22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.